LOS ANGELES, July 27 Dr. Lubov Shynkarenko, vice president and lead researcher of Pure Research Products, LLC, recently presented findings that demonstrate the company's probiotic-derived supplement's potential to support the immune system while it staves off viruses and infections like herpes and staph.
Advertisement
Mice were infected with herpes simplex virus-1 and Staphylococcus aureus for the study, which was revealed by Dr. Shynkarenko at this spring's International Probiotics Association (IPA) World Congress. Del-Immune V demonstrated strong protective action, with a significant increase in survival rate among mice that were given the product. Pure Research Products hopes these promising results will pave the way for clinical trials that further substantiate the effectiveness of the supplement's immune support for sufferers of viruses and infections. Del-Immune V is derived from the probiotic lactobacillus rhamnosus (DV strain), which was authored in the Ukraine by Dr. Shynkarenko.
Advertisement
"With so many probiotic products coming onto the market, we're advocating the careful research and analysis that helps the medical community and the consumer understand probiotic strains and the best conditions for their use," said Dr. Shynkarenko, former dean of the Biotechnology Institute at Kiev's elite National Technical University. "Fifty years of international research have gone into Del-Immune V, and it is still bearing new fruit today."
The research was presented at the International Probiotics Association (IPA) 2nd World Congress in Los Angeles this year, which was presented by European Food Safety Authority (EFSA) and attended by 220 delegates from the global probiotic industry. The meeting was CME approved for healthcare professionals, as the probiotic industry seeks to make more inroads into mainstream medicine.
About Del-Immune
Del-Immune V, manufactured by Boulder-based Pure Research Products, LLC (PRP), is a one-of-a-kind probiotic-derived nutritional supplement that provides immediate immune system support. Del-Immune represents the culmination of 50 years of research originated by Cold War-era Soviet Bloc scientists and Russian military bio-warfare troop protection programs. PRP obtained exclusive rights to manufacture, distribute and market the unique lactobacillus rhamnosus (DV strain) from its Russian partners in 2002. Del-Immune V is used by thousands and recommended by doctors around the world. For more information, please visit http://www.del-immune.com.
This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.
Contact: Nate Warren [email protected] 720.833.5924
SOURCE Pure Research Products, LLC
